Geneva Advisors’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$40.2M Buy
619,344
+542,982
+711% +$34.3M 0.69% 50
2017
Q1
$4.77M Buy
76,362
+67,412
+753% +$4.06M 0.09% 123
2016
Q4
$517K Buy
8,950
+495
+6% +$29.2K 0.01% 469
2016
Q3
$502K Buy
+8,455
New +$519K 0.01% 463

Other funds holding XRAY

Geneva Advisors's XRAY Position: Q2 2017 in Review

Geneva Advisors increased its Dentsply Sirona (XRAY) stake by 711% in Q2 2017, buying an estimated $34.3M and bringing the position to 619,344 shares worth $40.2M. The position accounts for 0.69% of the portfolio, ranked #50.

Geneva Advisors first reported a position in XRAY in Q3 2016 and has held it in 4 quarters since. 548 funds tracked by Wall St. Rank hold XRAY as of Q2 2017.

  • Geneva Advisors held 619,344 shares of Dentsply Sirona worth $40.2M as of Q2 2017.
  • Geneva Advisors bought 542,982 Dentsply Sirona shares in Q2 2017, an estimated $34.3M.
  • Dentsply Sirona made up 0.69% of Geneva Advisors's portfolio in Q2 2017, its #50 holding.
  • Geneva Advisors first reported a position in Dentsply Sirona in Q3 2016 and has held it in 4 quarters since.
  • 548 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.